Tekla Capital Management LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 108 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$6,049,000
+108.9%
289,029
+39.3%
0.23%
+75.6%
Q1 2020$2,895,000
-38.7%
207,5550.0%0.13%
-26.8%
Q4 2019$4,724,000
+95.4%
207,5550.0%0.18%
+70.5%
Q3 2019$2,418,000207,5550.10%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$11,354,00010.44%
RTW INVESTMENTS, LP 15,802,802$250,632,0005.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 63,000$17,884,0004.03%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,077,0004.02%
Prosight Management, LP 203,268$3,224,0002.08%
COWEN AND COMPANY, LLC 1,000,000$15,860,0001.53%
Boxer Capital, LLC 1,466,051$23,252,0001.20%
Cormorant Asset Management, LP 868,550$13,775,0001.06%
Amitell Capital Pte Ltd 97,331$1,544,0000.90%
SECTORAL ASSET MANAGEMENT INC 303,975$4,821,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders